Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Henkin

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|August 1, 1985
Squaric acid and esters: analysis for contaminants and stability in solventsM G Wilkerson, J Henkin, J K Wilkin, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1992
New developments in thrombolytic therapyS F Badylak, J Henkin, S E Burke, et al.
Biochemistry|May 17, 1988
Sequence-specific assignments in the 1H NMR spectrum of the human inflammatory protein C5aE R Zuiderweg, K W Mollison, J Henkin, et al.
Journal of Cellular Physiology|August 1, 1997
Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinaseS A Rabbani, J Gladu, A P Mazar, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1994
Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat modelD A Hart, P Whidden, F Green, et al.
Hematology/Oncology Clinics of North America|October 1, 1992
Approach to the patient with venous thromboembolism. Treatment with thrombolytic agentsA A Sasahara, C C St Martin, J Henkin, et al.
The Biochemical Journal|July 15, 1992
Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell lineW Hollas, E Soravia, A Mazar, et al.
Canadian Journal of Microbiology|December 1, 1993
Exogenous rh-urokinase modifies inflammation and Pseudomonas aeruginosa infection in a rat chronic pulmonary infection modelD A Hart, F Green, P Whidden, et al.
Thrombosis Research|November 15, 1988
Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosisS F Badylak, S Voytik, R E Klabunde, et al.
The Journal of Biological Chemistry|February 25, 1992
Domain structure and interactions of recombinant urokinase-type plasminogen activatorV Novokhatny, L Medved, A Mazar, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|August 1, 1985
Squaric acid and esters: analysis for contaminants and stability in solventsM G Wilkerson, J Henkin, J K Wilkin, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1992
New developments in thrombolytic therapyS F Badylak, J Henkin, S E Burke, et al.
Biochemistry|May 17, 1988
Sequence-specific assignments in the 1H NMR spectrum of the human inflammatory protein C5aE R Zuiderweg, K W Mollison, J Henkin, et al.
Journal of Cellular Physiology|August 1, 1997
Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinaseS A Rabbani, J Gladu, A P Mazar, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1994
Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat modelD A Hart, P Whidden, F Green, et al.
Hematology/Oncology Clinics of North America|October 1, 1992
Approach to the patient with venous thromboembolism. Treatment with thrombolytic agentsA A Sasahara, C C St Martin, J Henkin, et al.
The Biochemical Journal|July 15, 1992
Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell lineW Hollas, E Soravia, A Mazar, et al.
Canadian Journal of Microbiology|December 1, 1993
Exogenous rh-urokinase modifies inflammation and Pseudomonas aeruginosa infection in a rat chronic pulmonary infection modelD A Hart, F Green, P Whidden, et al.
Thrombosis Research|November 15, 1988
Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosisS F Badylak, S Voytik, R E Klabunde, et al.
The Journal of Biological Chemistry|February 25, 1992
Domain structure and interactions of recombinant urokinase-type plasminogen activatorV Novokhatny, L Medved, A Mazar, et al.
Pageof 8